与贝类消费相关的神经毒性藻毒素人类中毒:2012至2019年法国中毒控制中心登记病例研究
该研究为回顾性研究,复核法国中毒控制中心2012至2019年登记的619例双壳贝类(牡蛎、贻贝和扇贝)中毒病例。134例(22%)报告至少一种神经系统症状(头痛、头晕或感觉异常),复核后怀疑14例麻痹性贝类中毒和1例遗忘性贝类中毒,5例神经系统症状持续。这些患者未检测血或尿中的海洋毒素。该识别促使ANSES、中毒控制中心和Ifremer制定专门问卷,并推荐在中毒控制中心接到贝类消费相关神经系统症状报告时采取行动,同时在国家中毒控制中心数据库实施每日监测以快速发现可疑病例。
要点
- 2012至2019年法国中毒控制中心共登记619例贝类中毒,其中134例(22%)报告至少一种神经系统症状(头痛、头晕或感觉异常)。
- 复核134例病历后怀疑14例麻痹性贝类中毒和1例遗忘性贝类中毒,5例神经系统症状持续。
- 这些患者未检测血或尿中的海洋毒素。
- 2019年6月一例麻痹性贝类中毒与食用麻痹性贝类毒素浓度低于监管阈值的贻贝相关,提示可能存在未发现的人类中毒病例。
- ANSES、中毒控制中心和Ifremer据此制定专门问卷,并推荐在中毒控制中心接到贝类消费相关神经系统症状报告时采取行动;国家中毒控制中心数据库实施每日监测以快速发现可疑病例、警示主管部门并警告公众。
适用人群与场景
- 2012至2019年法国中毒控制中心登记的双壳贝类(牡蛎、贻贝和扇贝)中毒病例。
- 食用贝类后出现神经系统症状(头痛、头晕或感觉异常)的患者。
诊断标准与关键阈值
- 诊断基于与摄入污染贝类相符的症状,以及贝类生产区的污染数据(由法国海洋开发研究院Ifremer分析),或在贝类来源已知时基于欧洲食品和饲料快速预警系统的通报。
红旗征与不能漏的情况
- 食用贝类后出现神经系统症状(头痛、头晕或感觉异常)。
- 神经系统症状持续。
研究设计与关键结果
- 回顾性研究复核法国中毒控制中心2012至2019年登记的619例贝类中毒病例,所有病历由毒理学家复核。
- 619例中134例(22%)报告至少一种神经系统症状(头痛、头晕或感觉异常)。
- 复核134例病历后怀疑14例麻痹性贝类中毒和1例遗忘性贝类中毒。
- 5例患者神经系统症状持续。
- 这些患者未检测血或尿中的海洋毒素。
- 2019年6月一例麻痹性贝类中毒与食用麻痹性贝类毒素浓度低于监管阈值的贻贝相关。
证据类型、等级与局限
- 证据类型:回顾性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,2012至2019年病例的回顾性识别促使ANSES、中毒控制中心和Ifremer制定专门问卷,并推荐在中毒控制中心接到贝类消费相关神经系统症状报告时采取行动。
- 作者认为,国家中毒控制中心数据库实施每日监测以快速发现可疑病例、警示主管部门并警告公众。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
CONTEXT: In June 2019, a paralytic shellfish poisoning (PSP) case related to the consumption of mussels contaminated by saxitoxins at a concentration below the regulatory threshold came to the attention of the French Agency for Food, Environmental and Occupational Health and Safety (ANSES). This pointed to probable undetected human cases of poisoning by neurotoxic phycotoxins.
METHODS: We conducted a retrospective study of poisoning cases by bivalve shellfish (oysters, mussels and scallops) recorded by the French Poison Control Centres (PCC) from 2012 to 2019. All medical records were reviewed by a toxicologist.Cases that could be related to neurotoxic phycotoxins were selected and described. Diagnosis was based on symptoms compatible with ingestion of contaminated shellfish and on contamination data for the shellfish production area (analysed by the French Research Institute for Exploitation of the Sea, Ifremer), or notifications to the European Rapid Alert System for Food and Feed when the origin of the shellfish was known.
RESULTS: Among the 619 shellfish poisoning cases recorded by the PCCs from 2012 to 2019, 22% (n = 134) had reported at least one neurological symptom (headache, dizziness or paraesthesia). Review of medical records for the 134 patients led to suspicion of 14 cases of PSP and one case of amnesic shellfish poisoning. Five patients experienced persistent neurological symptoms. Marine toxins were not tested for in the blood or urine of these patients.
CONCLUSION: This retrospective identification of cases strongly suspected of being related to neurotoxic phycotoxins led ANSES, PCCs and Ifremer to develop a specific questionnaire and to recommend actions to take when neurological symptoms related to shellfish consumption are reported to a PCC. Daily monitoring of shellfish poisoning cases registered in the national PCCs database was also implemented in order to rapidly detect any suspicious cases, alert the competent authorities, and warn the general population.
参考来源
- Sinno-Tellier S, Abadie E, de Haro L, et al. Human poisonings by neurotoxic phycotoxins related to the consumption of shellfish: study of cases registered by the French Poison Control Centres from 2012 to 2019. Clin Toxicol (Phila). 2022. PMID: 35130811. doi:10.1080/15563650.2022.2034840
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。